Next Article in Journal
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
Next Article in Special Issue
Special Issue: “New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104)”
Previous Article in Journal
CNV Hotspots in Testicular Seminoma Tissue and Seminal Plasma
Previous Article in Special Issue
New Therapeutic Strategy for Overcoming Multidrug Resistance in Cancer Cells with Pyrazolo[3,4-d]pyrimidine Tyrosine Kinase Inhibitors
 
 
Review

Article Versions Notes

Cancers 2022, 14(1), 190; https://doi.org/10.3390/cancers14010190
Action Date Notes Link
article xml file uploaded 31 December 2021 10:57 CET Original file -
article xml uploaded. 31 December 2021 10:57 CET Update -
article pdf uploaded. 31 December 2021 10:57 CET Version of Record https://www.mdpi.com/2072-6694/14/1/190/pdf-vor
article html file updated 31 December 2021 10:58 CET Original file -
article xml file uploaded 4 January 2022 06:38 CET Update -
article xml uploaded. 4 January 2022 06:38 CET Update https://www.mdpi.com/2072-6694/14/1/190/xml
article pdf uploaded. 4 January 2022 06:38 CET Updated version of record https://www.mdpi.com/2072-6694/14/1/190/pdf
article html file updated 4 January 2022 06:40 CET Update -
article html file updated 4 January 2022 06:41 CET Update -
article html file updated 31 July 2022 01:28 CEST Update https://www.mdpi.com/2072-6694/14/1/190/html
Back to TopTop